Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors

Robust and accurate quantification of recombinant adeno-associated virus (rAAV) vectors’ infectivity is essential for pre-clinical and clinical development of AAV gene therapy programs. The industry standard method for rAAV titration is the 50% tissue culture infectious dose (TCID50) assay using HeL...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chloé Fustinoni, Xiang Liu, Zhi Chen, Ryan Cawood, Weimin Valenti, Maria I. Patrício, Weiheng Su
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-06-01
Col·lecció:	Molecular Therapy: Methods & Clinical Development
Matèries:	rAAV infectious titer TCID50 TESSA TREAT assay
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2329050125000877
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!